Amount Raised
$200 Million
Round Type
Debt Financing
PrincetonBiotechnologyHealthcareInvestors
Description
On February 26, 2026, UroGen Pharma Ltd. entered into a loan agreement to receive total funding of up to $250 million. The funding is structured in two tranches, with the first tranche of $200 million already provided. The second tranche of $50 million will be accessible upon the Borrower's election by June 30, 2027
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as UroGen Pharma that raised within 45 days of this round, from Fundz verified event records.
- ReAlta Life Sciences raised $40M (Funding Round) on April 8, 2026.
- Route 92 Medical raised $50M (Funding Round) on April 7, 2026.
- Bond Biosciences raised $5.9M on April 1, 2026.
- Artelo Biosciences raised $11M on March 27, 2026.
- Novel Microdevices raised $1M on March 27, 2026.
- Venus Concept Inc. raised $1.5M on March 26, 2026.
Who to call at UroGen Pharma, and when
A new round usually means UroGen Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day UroGen Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at UroGen Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at UroGen Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment UroGen Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
UroGen Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.